Former Indian cricketer Kapil Dev on Sunday said diabetes can be managed efficiently if people act in time and adhere to the right medication.

“In cricket, a partnership between two batsmen can be very damaging for the opposing team, and a bowler is always looking to end it sooner than later. Similarly, the partnership of weight and diabetes can be injurious for patients and must be managed in time. It is important to bowl out impending  complications before they stump you,” the former Indian cricket team captain said it as he launched the ‘Break the Partnership’ campaign at an event.

‘Break the Partnership’ campaign aims at educating the people with diabetes (PwD), their caregivers, and doctors about the grave influence of weight in type 2 diabetes (T2D).

Dev said, advances in science today allow for effective treatment options in type 2 diabetes that help with both blood sugar control as well as weight management.

“As a person with type 2 diabetes, I know that diabetes can be managed efficiently if we act in time and adhere to the right medication. I suggest and highly recommend that patients talk to their doctors about newer and progressive treatment options available for type 2 diabetes,” said the veteran Indian cricketer.

The multi-faceted campaign aims at spreading an awareness across the key stakeholders and encourage exploration of innovative and progressive medical solutions for weight management in diabetes.

Novo Nordisk, a global healthcare company in India, has partnered with the former Indian cricket team captain to launch ‘Break the Partnership’ campaign, which encourages people with diabetes to consult clinicians on newer treatment options that help manage both blood glucose as well as weight in T2D.

Announcing the launch of the campaign, Dev said, “I am glad to join Novo Nordisk in its effort to fight against diabetes. The ‘Break the Partnership’ #WeightinDiabetes campaign focuses on spreading awareness on the
harmful association of diabetes and weight, which must be tackled with utmost importance.”

Vikrant Shrotriya, Corporate Vice President and Managing Director, Novo Nordisk India and Dr Ambrish Mithal, Chairman & Head – Endocrinology & Diabetes, Max Super Speciality Hospital, Saket and Max Hospital, Gurgaon were also present on the occasion.